Metastatic Soft Tissue Sarcoma Recruiting Phase 1 Trials for Bevacizumab (DB00112)

Also known as: Metastatic Soft-tissue Sarcoma / Metastatic Soft-Tissue Sarcomas

IndicationStatusPhase
DBCOND0055864 (Metastatic Soft Tissue Sarcoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05075993Study of LVGN3616 and LVGN6051┬▒LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid TumorsTreatment